Visualising the effects of targeted therapies on patient tumours

Posted: 11 September 2017 | | No comments yet

The development of technology that can ‘see’ inside our bodies is one of the great achievements of modern medicine.1 For over 100 years, doctors have used imaging methods for this very reason to help guide patient care. Initially, two-dimensional x-ray pictures of bones and chests were used to help diagnose fractures and common lung diseases such as tuberculosis infection respectively.


However, in the last few decades the possibilities that medical imaging can offer have expanded hugely. This article considers the background to radiology in general, focuses on how pharmaceutical companies have used medical imaging in oncology drug development, and discusses how imaging may further assist strategic decision making in bringing new drugs to market.

Send this to a friend